跳至主要内容
临床试验/NCT03474939
NCT03474939已完成4 期

The Effect of Midazolam Premedication on Copeptine Concentration in Blood

Medical University of Warsaw1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年4月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Change in copeptin concentration

研究概览

简要总结

The study aim is to assess whether premedication with midazolam prior to surgery affects copeptin concentration in blood.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for elective surgery
  • Patients with no chronić illness and considered ASA 1 by anesthesiologist
  • Patients with mild and controlled chronic illness considered ASA 2 by anesthesiologist

排除标准

  • Patient refusal
  • Chronic illness requiring intense treatment or uncontrolled illness (ASA 3 or more)

研究组 & 干预措施

PLACEBO

Placebo Comparator

Patients receive 1000mg Glucose tablets night before and 60 minutes prior to surgery during premedication

干预措施: Placebo Oral Tablet (Other)

MIDAZOLAM

Active Comparator

Patients receive midazolam 7,5mg night before and 60 minutes prior to surgery as part of preanesthetic medication

干预措施: Midazolam Oral Tablet (Drug)

结局指标

主要结局

Change in copeptin concentration

时间窗: 48 hours

Change in the concentration of copeptine measured in blood serum

次要结局

未报告次要终点

研究者

发起方
Medical University of Warsaw
申办方类型
Other
责任方
Principal Investigator
主要研究者

Marek Janiak

Principal Investigator

Medical University of Warsaw

研究点 (1)

Loading locations...

相似试验